Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06860763Recruiting
Randomised, open-label trial in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Third Affiliated Hospital, Beijing University of Chinese Medicine. Primary endpoint: Swanson, Nolan, and Pelham-IV Questionnaire at 8 weeks. Started Oct 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06860763.